Thomas Muley
0000-0002-8141-0604
Publication & Citation Trends
Publications
0 total
Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis
Cited by 5
Semantic Scholar
A Plasma Proteomics Test Predicts Immunotherapy Benefit in NSCLC Independent of Genomic Alterations
Cited by 0
Semantic Scholar
TCF21 Deficiency Induces Fibroblast Apoptosis and Promotes Fibrotic Changes in the Human Lung Mesenchyme
Cited by 0
Semantic Scholar
Abstract 2763: A specific ribomethylome pattern in lung cancer is associated with increased risk of metastasis
Cited by 1
Semantic Scholar
PITX2 as a Sensitive and Specific Marker of Midgut Neuroendocrine Tumors: Results from a Cohort of 1157 Primary Neuroendocrine Neoplasms. OA
Cited by 7
Semantic Scholar
Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world study.
Cited by 11
Semantic Scholar
The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancer. OA
Cited by 4
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(156)
RNA modifications and cancer
(101)
Lung Cancer Diagnosis and Treatment
(82)
Lung Cancer Research Studies
(66)
Cancer Genomics and Diagnostics
(58)
Affiliations
Translational Research Institute
German Cancer Research Center
Friedrich-Alexander-Universität Erlangen-Nürnberg
Heidelberg University
Symbiosis International University